INDO US BIOTECH LTD (INDOUS)

NSE: ₹98.35
BSE: ₹98.00
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 19.14 34.96 22.11 37.88 24.72 22.17 23.56 33.38 30.77 30.85 22.80 26.02
YOY Revenue Growth % -100% 42.41% - 12.7% 29.12% -36.57% 6.56% -11.87% 24.48% 39.12% -3.25% -22.05%
Other Income 0.03 0.03 0.08 0.29 0.03 0.02 0.02 0.12 0.00 0.03 0.01 0.02
Total Income 19.17 34.99 22.19 38.17 24.75 22.19 23.58 33.50 30.77 30.87 22.80 26.05
Total Expenses + 16.72 30.57 18.44 33.78 21.56 17.74 18.57 29.63 25.95 27.31 19.64 23.67
Cost of Materials Consumed 7.75 19.92 13.83 0.00 12.62 11.14 16.37 30.83 8.84 19.50 15.60 34.41
Employee Benefit Expense 0.32 0.78 0.30 0.50 0.29 0.24 0.23 0.34 0.32 0.34 0.33 0.43
Other Expenses 1.50 -0.27 2.18 56.11 2.68 2.28 2.13 4.05 2.86 2.60 2.34 3.95
Operating Profit 2.42 4.39 3.68 4.10 3.16 4.43 5.00 3.76 4.82 3.53 3.16 2.36
OPM % 12.6% 12.6% 16.6% 10.8% 12.8% 20% 21.2% 11.3% 15.7% 11.5% 13.9% 9.1%
Profit Before Tax + 2.45 4.42 3.75 4.38 3.19 4.45 5.02 3.88 4.82 3.56 3.16 2.38
Tax Expense 0.07 4.42 3.75 4.38 0.02 0.09 -0.03 0.19 0.12 0.11 0.17 0.41
Tax % 3% 100% 100% 100% 0.6% 1.9% -0.5% 5% 2.4% 3% 5.3% 17.1%
Profit After Tax 2.37 0.00 0.00 0.00 3.17 4.36 5.04 3.68 4.70 3.45 3.00 1.97
EPS (Basic) 4.74 2.02 1.84 2.09 1.58 2.16 2.52 1.86 2.35 1.72 1.49 0.98

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019
Revenue from Operations 110.44 103.84 72.84 61.74 50.05 3,976,137.78 3,534,799.81
YOY Revenue Growth % 6.36% 42.56% 17.96% 23.36% -100% 12.49% -
Other Income 0.05 0.18 0.32 0.02 0.18 785.26 2,636.01
Total Income 110.49 104.02 73.16 61.77 50.24 3,976,923.04 3,537,435.82
Total Expenses + 96.57 87.49 64.35 54.38 44.75 3,689,530.90 3,256,363.26
Cost of Materials Consumed 78.35 70.96 0.00 42.97 2.18 2,667,856.13 538,703.35
Employee Benefit Expense 1.42 1.09 1.17 1.52 0.71 57,000.28 58,888.28
Other Expenses 11.74 11.15 80.46 5.73 6.26 337,667.60 374,086.77
Operating Profit 13.87 16.35 8.48 7.37 5.31 286,606.88 278,436.55
OPM % 12.6% 15.7% 11.6% 11.9% 10.6% 7.2% 7.9%
Profit Before Exceptional 13.92 16.53 0.00 0.00 0.00 287,392.14 0.00
Exceptional Items 0.00 0.00 0.00 0.00 0.00 -1,013.83 0.00
Profit Before Tax + 13.92 16.53 8.80 7.39 5.49 286,378.31 281,061.84
Tax Expense 0.80 0.26 8.80 7.39 5.49 32,905.69 281,061.84
Tax % 5.7% 1.6% 100% 100% 100% 11.5% 100%
Profit After Tax 13.12 16.27 0.00 0.00 0.00 253,472.62 0.00
EPS (Basic) 6.54 8.12 4.11 7.51 8.59 4.18 4.45

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 12.40 11.12 11.37 9.56 8.77 279,645.22 265,642.75
Property, Plant & Equipment 11.22 10.23 0.00 0.00 0.00 140,821.56 0.00
Capital Work in Progress 0.50 0.00 0.00 0.00 0.00 127,605.41 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 120.69 86.73 73.09 59.91 46.80 3,190,036.33 2,121,606.14
Inventories 99.95 70.69 51.74 26.91 23.36 914,795.50 1,071,321.19
Trade Receivables 13.76 15.00 0.00 0.00 0.00 2,097,684.31 0.00
Cash and Cash Equivalents 6.12 0.25 1.10 0.19 0.05 20,043.29 6,445.37
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 92.53 78.52 0.00 0.00 0.00 1,646,199.66 0.00
Equity Share Capital 20.05 20.05 0.00 0.00 0.00 606,799.00 0.00
Other Equity 72.48 58.47 0.00 0.00 0.00 1,039,400.66 0.00
Non-Current Liabilities 1.04 2.99 4.25 2.68 4.49 119,672.21 128,802.41
Current Liabilities 39.52 16.34 17.46 12.29 12.21 1,703,809.68 867,688.67
Total Liabilities 40.56 19.32 0.00 0.00 0.00 1,823,481.89 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2020 Mar 2019
Cash from Operating Activities -16.09 -1.42 -4.58 0.53 2.91 0.00 0.00
Cash from Investing Activities 3.27 -0.79 4.28 6.67 5.41 0.00 0.00
Cash from Financing Activities 24.44 -1.48 1.22 7.07 5.07 0.00 0.00
Net Increase/Decrease in Cash 11.88 -3.69 0.91 14.40 13.38 0.00 0.00